Y. Shimada

An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal Cancers

Y. Maehara, K. Sugimachi, T. Taguchi, 1999, Oncology.